Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PLG: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Plasminogen is a zymogen of plasmin, a serine protease involved in fibrinolysis, extracellular matrix remodeling, and neuronal plasticity. It plays critical roles in synaptic plasticity, neuroinflammation, and blood-brain barrier regulation, with implications for Alzheimer's disease, ALS, and stroke.
No AI portrait yet
| Gene Symbol | PLG |
| Full Name | Plasminogen |
| Chromosome | 6q26 |
| Function | tPA-mediated activation: Tissue plasminogen activator (tPA) activates plasminogen preferentially in the presence of fibrin, making it important for clot-specific fibrinolysis. |
| Primary Expression | neurons and can be released in response to neuronal activity |
| Amino Acids | 810 aa |
| UniProt ID | [P00747](https://www.uniprot.org/uniprot/P00747) |
| Ensembl ID | ENSG00000122194 |
| GeneCards | PLG |
| Human Protein Atlas | PLG |
| PAI-1 (SERPINE1) | Primary inhibitor of tPA and uPA |
| PAI-2 (SERPINE2) | Alternative inhibitor expressed in brain |
| Alpha-2 antiplasmin | Direct inhibitor of plasmin |
| Associated Diseases | Als, Inflammation, Ms |
| Interactions | NFKB1, TGFB1 |
| KG Connections | 37 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
PLG["PLG"]
Als{"Als"}
PLG -->|"associated with"| Als
Ms{"Ms"}
PLG -->|"associated with"| Ms
Inflammation{"Inflammation"}
PLG -->|"associated with"| Inflammation
Ferroptosis(["Ferroptosis"])
PLG -->|"associated with"| Ferroptosis
Complement(["Complement"])
PLG -->|"associated with"| Complement
neurodegeneration["neurodegeneration"]
PLG -->|"implicated in"| neurodegeneration
CD4["CD4"]
CD4 -->|"associated with"| PLG
MIRNAS["MIRNAS"]
MIRNAS -->|"associated with"| PLG
INFLAMMATION_RELATED_GENES["INFLAMMATION-RELATED GENES"]
INFLAMMATION_RELATED_GENES -->|"associated with"| PLG
INFLAMMATION["INFLAMMATION"]
INFLAMMATION -->|"associated with"| PLG
FERROPTOSIS["FERROPTOSIS"]
FERROPTOSIS -->|"associated with"| PLG
EGF["EGF"]
EGF -->|"associated with"| PLG
NR4A1["NR4A1"]
NR4A1 -->|"associated with"| PLG
style PLG fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| TGFB1 | activates | protein | 0.85 |
| Inflammation | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Ischemia | contributes_to | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| NFKB1 | inhibits | gene | 0.60 |
| IL30 | expressed_in | gene | 0.60 |
| Ferroptosis | associated_with | pathway | 0.60 |
| GENES | associated_with | gene | 0.60 |
| NEURON | contributes_to | gene | 0.60 |
| Immune Response | contributes_to | pathway | 0.60 |
| Complement | associated_with | pathway | 0.60 |
| CASP3 | associated_with | gene | 0.60 |
| EGF | associated_with | gene | 0.60 |
| PTEN | expressed_in | gene | 0.60 |
| EFNB2 | expressed_in | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| EGF | expressed_in | gene | 0.60 |
| VEGFA | expressed_in | gene | 0.60 |
| ANG | expressed_in | gene | 0.60 |
| ACTB | associated_with | gene | 0.60 |
| GAPDH | associated_with | gene | 0.60 |
| CD44 | associated_with | gene | 0.60 |
| HSP90AA1 | associated_with | gene | 0.60 |
| HGF | expressed_in | gene | 0.60 |
| CCL2 | expressed_in | gene | 0.60 |
| CDH1 | expressed_in | gene | 0.60 |
| CD4 | associated_with | gene | 0.60 |
| EGF | associated_with | gene | 0.60 |
| NR4A1 | associated_with | gene | 0.60 |
| MIRNAS | associated_with | gene | 0.60 |
| INFLAMMATION-RELATED GENES | associated_with | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| FERROPTOSIS | associated_with | gene | 0.60 |
| COMPLEMENT | contributes_to | gene | 0.60 |
| FN1 | associated_with | gene | 0.60 |
| AND | contributes_to | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PLG in their description or question text
No additional research found